Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00533884 · ClinicalTrials.gov registry record

Neurocognitive Functioning in Patients With Newly Diagnosed Upper Aerodigestive Tract Cancer Receiving Treatment at Henry-Joyce Cancer Clinic

A clinical trial, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
86
Enrollment target

NCT00533884 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 86 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00533884 has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
86 participants
Enrollment target

Study Summary

RATIONALE: Gathering information about how often problems with neurocognitive functioning occur in patients with newly diagnosed upper aerodigestive tract cancers may help doctors learn more about the disease. PURPOSE: This clinical trial is studying neurocognitive functioning in patients with newly diagnosed upper aerodigestive tract cancers receiving treatment at Henry-Joyce Cancer Clinic.

Interventions

  • OTHER Quality-of-life assessment
  • OTHER Assessment of therapy complications
  • OTHER Neurocognitive assessment

Trial Details

FieldValue
Enrollment Target 86 participants
Start Date 2007-10
Est. Completion 2013-06

What the Registry Record Tells You About NCT00533884

The ClinicalTrials.gov registry entry for NCT00533884 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Quality-of-life assessment is the first listed.

NCT00533884 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00533884 about?

NCT00533884 is a clinical study titled "Neurocognitive Functioning in Patients With Newly Diagnosed Upper Aerodigestive Tract Cancer Receiving Treatment at Henry-Joyce Cancer Clinic". RATIONALE: Gathering information about how often problems with neurocognitive functioning occur in patients with newly diagnosed upper aerodigestive tract cancers may help doctors learn more about the disease. PURPOSE: This clinical trial is studying neurocognitive functioning in patients with newl...

What is the current status of trial NCT00533884?

This trial is currently completed. The enrollment target is 86 participants. The study started on 2007-10. Estimated completion is 2013-06.

What interventions are being tested in trial NCT00533884?

The interventions under investigation include: Quality-of-life assessment (OTHER), Assessment of therapy complications (OTHER), Neurocognitive assessment (OTHER).

Who is sponsoring clinical trial NCT00533884?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.